首頁 > 市場調查報告書 > 製藥

呼吸器

市場調查報告書

商品編碼

1468567

2024-2032 年按產品（吸入器、霧化器）、適應症（氣喘、慢性阻塞性肺病）、配銷通路（零售藥房、醫院、線上藥局）和地區分類的慢性阻塞性肺病和氣喘設備市場報告

COPD and Asthma Devices Market Report by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Channel (Retail Pharmacies, Hospitals, Online Pharmacies), and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年，全球慢性阻塞性肺病及氣喘設備市場規模達457億美元。

慢性阻塞性肺病（COPD）是一種導致肺部氣流受阻的發炎性疾病。其早期症狀包括氣短、喘息、胸悶、慢性咳嗽（有或無黏液）、經常感冒和喉嚨痛。另一方面，氣喘，也稱為支氣管氣喘，是一種影響肺部氣道的呼吸系統疾病。其症狀包括呼吸急促、胸悶、睡眠困難、咳嗽或喘息。這些呼吸系統疾病可以使用各種有助於輸送吸入藥物的設備來治療。慢性阻塞性肺病和氣喘裝置，也稱為肺部藥物輸送裝置，用於呼吸系統疾病的永久治療或搶救治療。因此，它們在全球範圍內獲得了巨大的吸引力。

慢性阻塞性肺病和氣喘設備市場趨勢：

全球老年人口不斷成長，極易患慢性呼吸系統疾病，這是積極影響市場的關鍵因素之一。此外，由於吸菸增加而導致的呼吸系統疾病的發生率上升，也增加了慢性阻塞性肺病和氣喘設備的銷售量。除此之外，醫療保健支出的增加和醫療保健產業的持續自動化也促進了市場的成長。先進醫療解決方案的廣泛採用為全球製造商提供了利潤豐厚的成長機會。目前，醫療保健從業者和肺部疾病專家更喜歡藥物和設備的組合，因為它們的效果快速有效。此外，化學工業的擴張導致環境污染污染程度和呼吸問題日益嚴重，這反過來又推動了市場。此外，攜帶式藥物輸送設備的引入正在推動市場成長。

本報告回答的關鍵問題

2023 年全球慢性阻塞性肺病和氣喘設備市場規模？
2024-2032年全球慢性阻塞性肺病和氣喘設備市場的預期成長率為何？
推動全球慢性阻塞性肺病和氣喘設備市場的關鍵因素是什麼？
COVID-19 對全球慢性阻塞性肺病和氣喘設備市場有何影響？
基於該產品的全球慢性阻塞性肺病和氣喘設備市場的詳細情形如何？
根據適應症，全球慢性阻塞性肺病和氣喘設備市場的詳細情形如何？
基於配銷通路的全球慢性阻塞性肺病和氣喘設備市場的詳細情形如何？
全球慢性阻塞性肺病和氣喘設備市場的關鍵區域有哪些？
誰是全球慢性阻塞性肺病和氣喘設備市場的主要參與者/公司？

市場結構
關鍵參與者
關鍵參與者簡介
- Adherium Limited
- Aristopharma Ltd.
- AstraZeneca PLC
- Baxter International Inc.
- Boehringer Ingelheim International GmbH
- Cohero Health Inc.
- Koninklijke Philips NV
- Omron Corporation
- Pari Respiratory Equipment Inc.
- Recipharm AB
- Verona Pharma plc

簡介目錄圖表

Product Code: SR112024A6126

The global COPD and asthma devices market size reached US$ 45.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 69.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.

COPD and Asthma Devices Market Trends:

The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices. Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth. The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome. Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global COPD and asthma devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, indication and distribution channel.

Breakup by Product:

Inhalers

Drug Powdered Inhalers (DPIs)

Metered Dose Inhalers (MDIs)

Soft Mist Inhalers

Nebulizers

Compressor Nebulizers

Ultrasonic Nebulizers

Mesh Nebulizers

Breakup by Indication:

Asthma

COPD

Breakup by Distribution Channel:

Retail Pharmacies

Hospitals

Online Pharmacies

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.

Key Questions Answered in This Report

1. What was the size of the global COPD and asthma devices market in 2023?
2. What is the expected growth rate of the global COPD and asthma devices market during 2024-2032?
3. What are the key factors driving the global COPD and asthma devices market?
4. What has been the impact of COVID-19 on the global COPD and asthma devices market?
5. What is the breakup of the global COPD and asthma devices market based on the product?
6. What is the breakup of the global COPD and asthma devices market based on the indication?
7. What is the breakup of the global COPD and asthma devices market based on distribution channel?
8. What are the key regions in the global COPD and asthma devices market?
9. Who are the key players/companies in the global COPD and asthma devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global COPD and Asthma Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Inhalers
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Drug Powdered Inhalers (DPIs)
  - 6.1.2.2 Metered Dose Inhalers (MDIs)
  - 6.1.2.3 Soft Mist Inhalers
- 6.1.3 Market Forecast
6.2 Nebulizers
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Compressor Nebulizers
  - 6.2.2.2 Ultrasonic Nebulizers
  - 6.2.2.3 Mesh Nebulizers
- 6.2.3 Market Forecast

7 Market Breakup by Indication

7.1 Asthma
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 COPD
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

8.1 Retail Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Hospitals
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Online Pharmacies
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Adherium Limited
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Aristopharma Ltd.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 AstraZeneca PLC
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Baxter International Inc.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Boehringer Ingelheim International GmbH
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 Cohero Health Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Koninklijke Philips N.V.
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Omron Corporation
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Pari Respiratory Equipment Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 Recipharm AB
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
- 14.3.11 Verona Pharma plc
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2023
Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2023
Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2023
Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2023
Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
Table 7: Global: COPD and Asthma Devices Market: Key Players

02-2729-4219

+886-2-2729-4219